Overview

Scintigraphy Study to Assess Gastric Emptying in Healthy Subjects Given GSK716155 or Placebo.

Status:
Completed
Trial end date:
2008-04-04
Target enrollment:
Participant gender:
Summary
This study will use scintigraphy techniques to measure gastric emptying rate of liquid and solid food at baseline and after administration of GSK716155 or placebo.
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
rGLP-1 protein